Wockhardt Q1 FY27 Results: Turns Profitable, Net Profit ₹107 Cr
Wockhardt Ltd reported revenue from operations of ₹929 Cr (+25.9% YoY) and net profit of ₹107 Cr for Q1 FY27.
- Key figure
- Net profit ₹107 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
Wockhardt Ltd reported revenue from operations of ₹929 Cr (+25.9% YoY) and net profit of ₹107 Cr for Q1 FY27.
Wockhardt reports FY26 revenue of ₹3,373cr with 51% EBITDA growth. Strategy focuses on novel antibiotic 'Zaynich', recently US FDA approved, and diabetes biosimilars to drive future scaling.
Wockhardt FY26 revenue reached INR 3,373 Cr with EBITDA of INR 630 Cr (18.6% margin). Strategy focuses on Novel Antibiotics (Zaynich) and Biosimilars.
Wockhardt Ltd reported revenue from operations of ₹965 Cr (+29.9% YoY) and net profit of ₹164 Cr for Q4 FY26.